Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL)
CUSIP: 05337M104
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share
- Shares outstanding
- 98,762,388
- Total 13F shares
- 600,001
- Share change
- -137,500
- Total reported value
- $12,930,016
- Price per share
- $18.78
- Number of holders
- 2
- Value change
- -$2,099,625
- Number of sells
- 1
Quarterly Holders Quick Answers
What is CUSIP 05337M104?
CUSIP 05337M104 identifies AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q3 2025
Recent filing periods for CUSIP 05337M104:
Top shareholders of AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC |
13F
13D/G
|
Company |
1.9%
from 13D/G
|
7,429,718
|
$113,425,183 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
7%
from 13D/G
|
6,973,658
|
$106,487,759 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
13D/G
|
Company · The Vanguard Group |
5.7%
from 13D/G
|
5,606,282
|
$85,607,927 | — | 30 Sep 2025 | |
| BRANDES INVESTMENT PARTNERS, LP |
13F
13D/G
|
Company |
0.2%
from 13D/G
|
5,444,803
|
$83,142,141 | — | 30 Sep 2025 | |
| Two Seas Capital LP |
13F
|
Company |
5.6%
|
5,369,082
|
$81,985,882 | — | 30 Sep 2025 | |
| Jeffrey L. Gendell |
13F
13D/G
|
Individual |
4.9%
from 13D/G
|
5,314,810
|
$81,157,148 | — | 30 Sep 2025 | |
| Polar Capital Holdings Plc |
13F
|
Company |
4.2%
|
3,999,338
|
$61,069,891 | — | 30 Sep 2025 | |
| Vivo Capital, LLC |
13F
|
Company |
2.8%
|
2,684,109
|
$40,986,344 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.4%
|
2,292,607
|
$35,008,109 | — | 30 Sep 2025 | |
| WEALTH EFFECTS LLC |
13F
|
Company |
2.4%
|
2,288,813
|
$34,950,169 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
2.4%
|
2,258,683
|
$34,490,101 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
2,175,777
|
$33,229,414 | — | 30 Sep 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.2%
|
2,097,500
|
$32,028,825 | — | 30 Sep 2025 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.7%
|
1,626,818
|
$24,841,511 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.4%
|
1,338,742
|
$20,442,590 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.1%
|
1,057,886
|
$16,153,919 | — | 30 Sep 2025 | |
| Krensavage Asset Management, LLC |
13F
|
Company |
1%
|
955,860
|
$14,596,000 | — | 30 Sep 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.93%
|
897,086
|
$13,698,503 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.89%
|
856,841
|
$13,083,963 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.83%
|
799,483
|
$12,208,105 | — | 30 Sep 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.79%
|
754,378
|
$11,519,352 | — | 30 Sep 2025 | |
| Tri Locum Partners LP |
13F
|
Company |
0.76%
|
724,859
|
$11,068,597 | — | 30 Sep 2025 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.72%
|
688,988
|
$10,520,847 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.71%
|
677,981
|
$10,352,770 | — | 30 Sep 2025 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.7%
|
675,504
|
$10,314,946 | — | 30 Sep 2025 | |
| Knoll Capital Management, LLC |
13F
|
Company |
0.61%
|
600,000
|
$9,162,000 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.59%
|
565,471
|
$8,634,741 | — | 30 Sep 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.58%
|
559,576
|
$8,544,726 | — | 30 Sep 2025 | |
| Modera Wealth Management, LLC |
13F
|
Company |
0.58%
|
558,972
|
$8,535,503 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.58%
|
556,100
|
$8,491,647 | — | 30 Sep 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.58%
|
554,493
|
$8,467,108 | — | 30 Sep 2025 | |
| Jump Financial, LLC |
13F
|
Company |
0.57%
|
549,831
|
$8,395,920 | — | 30 Sep 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.57%
|
542,613
|
$8,285,701 | — | 30 Sep 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.55%
|
525,705
|
$8,027,516 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.54%
|
523,072
|
$7,987,310 | — | 30 Sep 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.54%
|
514,293
|
$7,853,254 | — | 30 Sep 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.48%
|
457,340
|
$6,983,582 | — | 30 Sep 2025 | |
| Trexquant Investment LP |
13F
|
Company |
0.43%
|
410,500
|
$6,268,335 | — | 30 Sep 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.42%
|
400,123
|
$6,109,878 | — | 30 Sep 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.39%
|
369,629
|
$5,644,235 | — | 30 Sep 2025 | |
| David M. Knott Jr. |
13F
|
Individual |
0.38%
|
363,000
|
$5,543,010 | — | 30 Sep 2025 | |
| AWM Investment Company, Inc. |
13F
|
Company |
0.33%
|
316,189
|
$4,828,206 | — | 30 Sep 2025 | |
| Caption Management, LLC |
13F
|
Company |
0.32%
|
308,445
|
$4,709,955 | — | 30 Sep 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.3%
|
285,460
|
$4,358,974 | — | 30 Sep 2025 | |
| IRIDIAN ASSET MANAGEMENT LLC/CT |
13F
|
Company |
0.26%
|
249,586
|
$3,811,178 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.26%
|
248,151
|
$3,789,257 | — | 30 Sep 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.25%
|
239,881
|
$3,662,983 | — | 30 Sep 2025 | |
| MML INVESTORS SERVICES, LLC |
13F
|
Company |
0.24%
|
227,393
|
$3,472,291 | — | 30 Sep 2025 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.19%
|
182,590
|
$2,788,000 | — | 30 Sep 2025 | |
| Swiss National Bank |
13F
|
Company |
0.18%
|
168,000
|
$2,565,360 | — | 30 Sep 2025 |
Institutional Holders of Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL) as of Q4 2025
As of 31 Dec 2025,
Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL) was held by
2 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
600,001 shares.
The largest 2 holders included
Knoll Capital Management, LLC and HUNTINGTON NATIONAL BANK.
This page lists
2
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
3
Q4 2025 holders
2
Holder diff
-1
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.